This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Genzyme Corporation, True North Therapeutics, Inc.. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Karen Sue Christopherson: Innovator in Complement-Mediated Disorders
Introduction
Karen Sue Christopherson is a notable inventor based in San Mateo, CA. She has made significant contributions to the field of medicine, particularly in the area of complement-mediated disorders. With a total of 3 patents, her work has the potential to impact many lives.
Latest Patents
Karen's latest patents include "Anti-complement factor Bb antibodies and uses thereof." This patent provides anti-complement factor Bb antibodies and compositions comprising these antibodies. The anti-Bb antibodies are useful for treating complement-mediated disorders. Additionally, she holds another patent titled "Anti-complement factor BB antibodies and uses thereof," which similarly focuses on the treatment of complement-mediated disorders through the use of these antibodies.
Career Highlights
Karen is currently employed at Genzyme Corporation, where she continues to innovate and develop new treatments. Her work is crucial in advancing the understanding and management of complement-mediated disorders.
Collaborations
Some of her notable coworkers include Sandip Panicker and Graham Parry, who contribute to her research and development efforts.
Conclusion
Karen Sue Christopherson is a pioneering inventor whose work in anti-complement factor antibodies is paving the way for new treatments in medicine. Her contributions are invaluable to the field and hold promise for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile